ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 726767 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 726767; 2) Community: the network communities that were significantly associated with the response to NSC 726767; 3) Molecule: the relationships between components within communities and NSC 726767; 4) MDR: the compounds that were significantly associated with the NSC 726767.

NSC Compound Enrichment Correlation
NSC 736761 16-[3-(2-morpholin-1-yl ethoxy)benzylidene]-5-androstene-3b,17b-diol diacetate 0.0352383000003058 0.23286101
NSC 740345 3-3'-(1H-pyrazole-3,5-diyl)bis(1-methyl-1H-indole) 0.0352383000003058 0.34548836
NSC 741296 Null 0.0352383000003058 0.33707194
NSC 748512 Null 0.0352383000003058 0.10130516
NSC 751342 12H-Benzo[g]pyrido[2,1-b]quinazoline-4-carboxamide, N-[2(dimethylamino)ethyl]-12-oxo 0.0352383000003058 0.54615743
NSC 7521 [(6-Deoxy-.alpha.-L-mannopyranosyl)oxy]-14-hydroxybufa-4,20,22-trienolide 0.0352383000003058 0.30315602
NSC 753189 3,5-dichloro-N-(4-(3-(4-chloro-3-methoxyphenyl)-4-(pyridin-4-yl)-1H-pyrazol-1-yl)phenyl)benzamide 0.0352383000003058 0.2622529
NSC 79037 Lomustine 0.0352383000003058 0.38767097
NSC 87221 Actinomycin D, 2A-D-alloisoleucine- (9CI) 0.0352383000003058 0.40328968
NSC 89671 Ascotoxin 0.0352383000003058 -0.14201003
Total:127  Current:99    [First] [Prev] [Next] [Last]